The GDF6-FTO axis modulates the innate immune and inflammatory response to human respiratory syncytial virus

Zhu Li1, Ling Zhang1, Yi Liu2

  • 1Department of Respiratory Medicine, The First People's Hospital of Zunyi (The Third Affiliated Hospital of Zunyi Medical University), Zunyi, Guizhou 563000, China.

Iscience
|October 30, 2024
PubMed

Insights

N6-methyladenosine (m6A) modifications are altered during respiratory syncytial virus (RSV) infection. The demethylase FTO stabilizes GDF6 mRNA, boosting antiviral immunity and reducing inflammation.

Area of Science:

  • Virology
  • Molecular Biology
  • Immunology

Background:

  • Respiratory syncytial virus (RSV) is a major respiratory pathogen with no specific antiviral drugs.
  • N6-methyladenosine (m6A) RNA modification plays a role in regulating viral infections.

Purpose of the Study:

  • To investigate the role of m6A modifications in host antiviral immunity against RSV.
  • To identify specific m6A regulators involved in the host response to RSV infection.

Main Methods:

  • Analysis of m6A modification levels in RSV-infected samples.
  • Investigating the function of FTO and IGF2BP1 in regulating GDF6 expression and interferon production.
  • Assessing the impact of these modifications on antiviral responses.

Main Results:

  • RSV infection alters host m6A modification patterns.
  • Depletion of FTO enhances type I interferon (I-IFN) production and reduces pro-inflammatory factors by stabilizing GDF6 mRNA.
  • IGF2BP1 deficiency decreases GDF6 expression and subsequently reduces I-IFN production.

Conclusions:

  • RSV infection induces changes in host m6A modifications.
  • FTO-mediated m6A modifications are crucial for antiviral immunity against RSV by enhancing GDF6 mRNA stability and translation.

Related Concept Videos

Immune Response Against Viral Pathogens01:29

Immune Response Against Viral Pathogens

The immune system's response to viral infections is a complex and coordinated process involving natural killer (NK) cells, T cell-mediated responses, and antibody-mediated responses.
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...
754
Pneumonia II: Pathophysiology01:29

Pneumonia II: Pathophysiology

The pathophysiology of pneumonia involves the following steps:
225
Inflammatory Response01:28

Inflammatory Response

An inflammatory response is a localized, nonspecific immune reaction that occurs when a tissue is injured. It is characterized by redness, swelling, heat, and pain, which are commonly called the cardinal signs and symptoms of inflammation. Inflammation can sometimes result in a loss of function.
Inflammation can be triggered by various stimuli, such as impact, abrasion, chemical irritation, infections, and extreme hot or cold temperatures. These can damage cells and connective tissue fibers,...
1.9K
Cystic Fibrosis: Pathogenesis01:23

Cystic Fibrosis: Pathogenesis

Cystic fibrosis (CF), an autosomal recessive disorder, significantly affects the function of exocrine glands. This genetically inherited disease is characterized by the production of thick and sticky mucus, which can severely affect various organs and systems in the body.
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...
192
Cells of the Innate Immune Response01:28

Cells of the Innate Immune Response

The innate immune response is an immediate and non-specific response against pathogens, acting swiftly to prevent the spread of infections. The primary cells involved in this response are phagocytes and natural killer (NK) cells.
Phagocytes
Phagocytes police the peripheral tissues by removing cellular debris and responding to the invasion of foreign substances or pathogens. Many phagocytes attack and remove microorganisms even before lymphocytes detect them. The human body has two general...
1.6K
Acute Respiratory Failure-II01:21

Acute Respiratory Failure-II

Type I Respiratory Failure, or hypoxemic respiratory failure, occurs when the partial pressure of oxygen (PaO2) in arterial blood falls below 60 mmHg while breathing room air without a corresponding increase in arterial carbon dioxide levels (PaCO2). This condition highlights a significant impairment in the lungs' capacity to oxygenate the blood.
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
174